Department of Hepatology, The First Affiliated Hospital of Hunan University of Chinese Medicine, Changsha, 410007 Hunan Province, China.
Biomed Res Int. 2021 Nov 26;2021:9140602. doi: 10.1155/2021/9140602. eCollection 2021.
T-helper 17 (Th17) and CD4CD25 T-regulatory (Treg) cells play important roles in the pathogenesis of hepatitis B virus-related acute-on-chronic liver failure (HBV-ACLF). This study is aimed at investigating shifts in Treg/Th17 balance in the peripheral blood of HBV-ACLF patients at different disease stages.
Sixty HBV-ACLF patients, admitted to the First Hospital of Hunan University of Chinese Medicine, China, including early-stage ( = 20), middle-stage ( = 20), and late-stage patients ( = 20), were enrolled in the study. In addition, 20 patients with chronic hepatitis B and 20 healthy volunteers were also included in the study as controls. Flow cytometry, cytometric bead array, and quantitative real-time PCR protocols were used to evaluate the expression of Treg and Th17 cells as well as of related cytokines.
The levels of Th17 cells and their effectors interleukin- (IL-) 17A, IL-23, and tumor necrosis factor- increased with disease progression. Similarly, Treg cells and their effector cytokines transforming growth factor- and IL-10 also increased. Although Treg and Th17 levels were positively correlated, the latter were always at higher numbers. Noteworthy, the Treg/Th17 ratio gradually decreased and was negatively correlated with ACLF severity. levels in the peripheral blood gradually decreased with ACLF progression, whereas gradually increased. Serum c-reactive protein, procalcitonin, and lipopolysaccharide were also upregulated with disease progression and positively correlated with Th17 abundance. Further, Th17, IL-17A, and IL-23 were independent risk factors for ACLF. A prognostic model for HBV-ACLF was established, with a correct prediction rate of 90.00% (54/60).
Treg/Th17 imbalance occurs throughout the pathogenic course of HBV-ACLF, with an imbalance shift toward Th17. Hence, the Th17-mediated inflammatory response drives HBV-ACLF-associated inflammation and supports the pathological mechanisms of liver failure.
辅助性 T 细胞 17(Th17)和 CD4+CD25+调节性 T(Treg)细胞在乙型肝炎病毒相关慢加急性肝衰竭(HBV-ACLF)的发病机制中发挥重要作用。本研究旨在探讨 Treg/Th17 平衡在 HBV-ACLF 患者不同疾病阶段外周血中的变化。
纳入中国湖南中医药大学第一附属医院的 60 例 HBV-ACLF 患者,包括早期(n=20)、中期(n=20)和晚期(n=20)患者,同时纳入 20 例慢性乙型肝炎患者和 20 例健康志愿者作为对照。采用流式细胞术、细胞因子微珠阵列和实时定量 PCR 方案评估 Treg 和 Th17 细胞及其相关细胞因子的表达。
Th17 细胞及其效应因子白细胞介素-(IL-)17A、IL-23 和肿瘤坏死因子-随着疾病的进展而增加。同样,Treg 细胞及其效应细胞因子转化生长因子-和 IL-10 也增加。尽管 Treg 和 Th17 水平呈正相关,但后者的数量总是更高。值得注意的是,Treg/Th17 比值逐渐降低,与 ACLF 严重程度呈负相关。外周血中 水平随着 ACLF 的进展逐渐降低,而 水平逐渐升高。血清 C 反应蛋白、降钙素原和脂多糖也随着疾病的进展而升高,并与 Th17 丰度呈正相关。此外,Th17、IL-17A 和 IL-23 是 ACLF 的独立危险因素。建立了 HBV-ACLF 的预测模型,正确预测率为 90.00%(54/60)。
Treg/Th17 失衡发生在 HBV-ACLF 的整个发病过程中,向 Th17 倾斜。因此,Th17 介导的炎症反应驱动 HBV-ACLF 相关炎症,并支持肝衰竭的病理机制。